|
Market Closed -
Nasdaq
02:30:00 20/11/2024 am IST
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 21/24/21 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 20/24/20 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
| Market Cap | 50Cr 66Cr 59Cr 55Cr 94Cr 6.39TCr 95Cr 660.76Cr 258.08Cr 3.25TCr 247.71Cr 242.57Cr 10TCr | P/E 2022 |
-4.55x | P/E 2023 | -4.28x |
|---|---|---|---|---|---|
| Enterprise Value | 16Cr 21Cr 18Cr 17Cr 29Cr 1.99TCr 30Cr 205.84Cr 80Cr 1.01TCr 77Cr 76Cr 3.25TCr | EV / Sales 2022 |
1.9x | EV / Sales 2023 | 14.2x |
| Free-Float |
36.87% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +3.20% |
| 3 years | 3.8 |  | 7.91 |
| 5 years | 3.8 | | 25.16 |
| 10 years | 3.8 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 61 | 06/06/2024 | |
| Chief Tech/Sci/R&D Officer | - | 01/05/2022 | |
John Overington
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Polywka
BRD | Director/Board Member | 63 | 28/09/2017 |
Robert Ghenchev
BRD | Director/Board Member | 43 | 01/05/2020 |
Elizabeth Crain
CHM | Chairman | 61 | 12/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -.--% | -.--% | +4.09% | 63Cr | |
| +4.16% | +4.16% | +49.37% | +94.17% | 7.47TCr | |
| +0.46% | -1.16% | +23.36% | +79.34% | 5.88TCr | |
| +0.17% | -1.16% | +3.59% | +34.55% | 4.84TCr | |
| +0.50% | -1.77% | +331.24% | +702.20% | 4.28TCr | |
| -0.72% | -4.04% | +25.90% | +29.94% | 4.28TCr | |
| +0.34% | -0.34% | +5.66% | +109.35% | 4.12TCr | |
| -0.11% | +1.96% | +9.19% | +52.66% | 3.11TCr | |
| -2.07% | +1.16% | +35.00% | +26.28% | 3.03TCr | |
| -0.50% | -3.37% | -9.42% | -14.35% | 2.4TCr | |
| Average | +0.54% | -0.23% | +47.39% | +111.82% | 3.95TCr | |
| Weighted average by Cap. | +0.70% | -0.54% | +55.42% | +130.00% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 2.72Cr 3.6Cr 3.21Cr 3Cr 5.12Cr 347.96Cr 5.17Cr 36Cr 14Cr 176.94Cr 13Cr 13Cr 568.24Cr | 2.01Cr 2.65Cr 2.37Cr 2.21Cr 3.78Cr 256.64Cr 3.81Cr 27Cr 10Cr 130.51Cr 9.95Cr 9.74Cr 419.12Cr |
| Net income | -12Cr -16Cr -14Cr -13Cr -22Cr -1.52TCr -23Cr -156.95Cr -61Cr -771.7Cr -59Cr -58Cr -2.48TCr | -15Cr -19Cr -17Cr -16Cr -27Cr -1.87TCr -28Cr -192.96Cr -75Cr -948.72Cr -72Cr -71Cr -3.05TCr |
| Net Debt | -49Cr -65Cr -58Cr -54Cr -93Cr -6.29TCr -93Cr -650.29Cr -253.99Cr -3.2TCr -243.78Cr -238.72Cr -10TCr | -34Cr -45Cr -41Cr -38Cr -65Cr -4.4TCr -65Cr -454.92Cr -177.68Cr -2.24TCr -170.54Cr -167Cr -7.18TCr |
Employees
483
- Stock Market
- Stocks
- EXAI Stock
Select your edition
All financial news and data tailored to specific country editions
